Back

Predictors of new cancer diagnosis following a NSTEMI event: insights from a national cancer registry

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology and non-ischaemic coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yuval Yarkoni

The Chaim Sheba Medical Center, Tel Hashomer (Israel)

6 More presentations in this session

Presentation thumbnail
Nutritional and Inflammatory Status are Associated with Obesity Paradox in Coronary Artery Disease Patients Without Cancer
Doctor Y. Shirahama (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of advanced lung cancer inflammation index in predicting 1-year mortality post-PCI in STEMI patients
Doctor G. Trimarchi (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Short-term outcomes of impella support in japanese patients with cardiogenic shock due to non-ischemic cardiomyopathy
Doctor M. Nishiwaki (Kawaguchi, JP)
Abstract Slides Video
Presentation thumbnail
Fulminant Myocarditis: clinical profile, outcomes and comparison with myocardial infarction-related cardiogenic shock
Doctor E. Garcia Martin (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Lymphoma and long term outcomes after percutaneous coronary intervention
Miss I. Reeves (Riga, LV)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology and non-ischaemic coronary syndromes

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of cancer history on non-ST-segment elevation myocardial infarction (NSTEMI) prognosis, a propensity-score matching (PSM) analysis
thumbnail
Congress Presentation
Cardiovascular outcomes, mortality, and bleeding in patients with acute myocardial infarction and a history of cancer: a report from the multi-center, nationwide prospective database JAMIR
thumbnail
Congress Presentation
Cardiovascular disease is a significant contributor to the incidence of cancer, second-primary cancer, and cancer-related hospitalization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources